DUBAI, UAE, May 15, 2023 /PRNewswire/ — According to the latest research report published by Extrapolate, the global Regenerative Medicine Market is poised to experience substantial growth and accrue a market size of USD 127.86 billion by 2032, recording a CAGR of 17% between 2023 and 2032. This is a significant increase from the base … Read more
The expansion of the ambulatory polysomnography (PSG) systems market is heavily influenced by the incidence of various sleep disorders, which creates attractive prospects for market growth. The North America region is projected to garner the highest revenue by 2031. PORTLAND, Ore., May 15, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Ambulatory Polysomnography … Read more
Company’s advanced generative AI-powered cloud platform creates clarity around healthcare pricing, coverage for consumers, employers, government agencies, hospitals, insurance companies and other businesses in the healthcare industry SEATTLE, May 15, 2023 /PRNewswire/ — Cascade Health, an intelligent platform for healthcare transparency, announced it has raised $1.7 million in venture funding led by AlleyCorp with participation … Read more
Natrol is on a Mission This Mental Health Awareness Month to Help Consumers Break the Sleep Stress Cycle Through New “Wake Up Call” Campaign SHERMAN OAKS, Calif., May 15, 2023 /PRNewswire/ — A recent survey* of the Sleep Stress Cycle taken by 2,000 adults shows that 9 out of 10 (92%) agree they’re less stressed … Read more
The transition for ACG is making progress in 2023 CHICAGO, May 15, 2023 /PRNewswire/ — Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months and Quarter Ending March 31, 2023. Revenues for the quarter ending March 31, 2023 (“Q1 2023”) were $845,676 Gross … Read more
TORRANCE, Calif., May 15, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023. Recent Highlights “We enjoyed a fifth straight increase in … Read more
Successful top line results from Phase 2a clinical trial for lead candidate LP-10 Oral Health Scientific Advisory Board established to focus on development of LP-310 for oral lichen planus Late-breaking presentation of Phase 2a study results at the American Urological Association Annual Meeting Manufacturing collaboration agreement with Cook MyoSite in anticipation of Lipella’s forthcoming Investigational … Read more
The primary efficacy endpoint of PARADIGM, (NCT05357950), is the assessment of ALS-biomarkers to evaluate PrimeC and its biological activity. Secondary endpoints include the clinical outcome measures Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R), Slow Vital Capacity (SVC), and overall survival, as well as safety and tolerability, in addition to a robust battery of additional biomarkers … Read more
Nationally recognized physician executive and healthcare thought leader will serve in strategic advisory role to leading industry society serving more than 100,000 healthcare finance professionals SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Today Innovaccer Inc. announced that Chief Medical Officer David Nace, MD has joined the Healthcare Financial Management Association’s (HFMA) Healthcare Leadership Council (HLC). As … Read more
DENVER, May 15, 2023 /PRNewswire/ — Onus iV Hydration, a first to market iV company, built for active living a mile above sea level, is excited to announce the launch of its franchise program. The company has successfully built and operated 5 locations in the Front Range since its inception in 2015. Working with the … Read more